Global Allergy Drugs Market Up 232% Due To


[ad_1]

Dublin, April 29, 2020 (GLOBE NEWSWIRE) – ResearchAndMarkets.com published a new article on the allergy drug industry, “Global Allergy Drug Market Grows 232% Due to COVID-19”

The coronavirus outbreak has straddled the spring allergy season and health officials have advised allergy sufferers to ensure they have a supply of antiallergic drugs such as antihistamines, nasal sprays and barrier balms allergens. This advice is particularly important for people with asthma who are advised to continue their normal breathing treatments and to wear a rescue inhaler at all times.

This has created a huge demand for over-the-counter and prescription allergy medications as consumers stock up on needed medications. The United States has seen a surge in demand for Albuterol from hospitals and consumers. Albuterol, sold under the brand names Ventolin and Pro Air, is a bronchodilator commonly used as a rescue treatment for asthma attacks. It is also used in hospitals as an alternative to nebulizers for patients with COVID-19 to reduce the risk of aerosolizing the virus.

To view the full article and a list of related reports in the market, visit “Global Allergy Drug Market Grows 232% Due to COVID-19”

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for market research reports and international market data. We provide you with the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

Research and Markets also offers Custom Search services providing targeted, comprehensive and appropriate research.


[ad_2]

Comments are closed.